Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 6, 2009, Pages 837-843

  Nikitakis, Nikolaos G ^a   Scheper, Mark A ^b,c   Papanikolaou, Vasileios S ^d   Sklavounou, Alexandra ^a   Sauk, John J ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; STAT3 PROTEIN;

ARTICLE; CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SALIVARY GLAND DISEASE; SALIVARY GLAND TUMOR; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

CARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; SALIVARY GLAND DISEASES; SALIVARY GLAND NEOPLASMS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TISSUE DISTRIBUTION;

EID: 67349177031     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.12.052     Document Type: Article

References (39)

1. Neville B.W., Damm D.D., Allen C.M., and Bouquot J.E. Salivary gland pathology. In: Neville B.W., Damm D.D., Allen C.M., and Bouquot J.E. (Eds). Oral and maxillofacial pathology. 2nd ed. (2002), Saunders, Philadelphia 406-430
2. Agulnik M., and Siu L.L. An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents. Curr Med Chem Anticancer Agents 4 (2004) 543-551
3. Stenman G. Fusion oncogenes and tumor type specificity-insights from salivary gland tumors. Semin Cancer Biol 15 (2005) 224-235
4. Licitra L., Locati L.D., Bossi P., and Cantu G. Head and neck tumors other than squamous cell carcinoma. Curr Opin Oncol 16 (2004) 236-241
5. Pramoonjago P., Baras A.S., and Moskaluk C.A. Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene 25 (2006) 5626-5639
6. Li J., El-Naggar A., and Mao L. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma. Cancer 104 (2005) 771-776
7. Kaye F.J. Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer. Clin Cancer Res 12 (2006) 3878-3881
8. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., et al. Stat3 as an oncogene. Cell 98 (1999) 295-303
9. Buettner R., Mora L.B., and Jove R. Activated Stat signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8 (2002) 945-954
10. Kijima T., Niwa H., Steinman R.A., Drenning S.D., Gooding W.E., Wentzel A.L., et al. Stat3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo. Cell Growth Differ 13 (2002) 355-362
11. Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., et al. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A 97 (2000) 4227-4232
12. Nikitakis N.G., Siavash H., and Sauk J.J. Targeting the Stat pathway in head and neck cancer: recent advances and future prospects. Curr Cancer Drug Targets 4 (2004) 637-651
13. Bowman T., Garcia R., Turkson J., and Jove R. Stats in oncogenesis. Oncogene 19 (2000) 2474-2488
14. Bromberg J.F. Activation of Stat proteins and growth control. Bioessays 23 (2001) 161-169
15. Li F. Survivin study: what is the next wave?. J Cell Physiol 197 (2003) 8-29
16. Kanda N., Seno H., Konda Y., Marusawa H., Kanai M., Nakajima T., et al. Stat3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23 (2004) 4921-4929
17. Aoki Y., Feldman G.M., and Tosato G. Inhibition of Stat3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101 (2003) 1535-1542
18. Lo Muzio L., Pannone G., Staibano S., Mignogna M.D., Rubini C., Mariggio M.A., et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 89 (2003) 2244-2248
19. Scheper M.A., Sauk J.J., and Nikitakis N.G. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin downregulation. Anticancer Res 26 (2006) 4103-4113
20. Scheper M.A., Nikitakis N.G., and Sauk J.J. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer. Int J Oral Maxillofac Surg 36 (2007) 632-639
21. Piechocki M.P., Yoo G.H., Dibbley S.K., Amjad E.H., and Lonardo F. Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu. Int J Cancer 119 (2006) 441-454
22. Wen X., Lin H.H., Shih H.M., Kung H.J., and Ann D.K. Kinase activation of the nonreceptor tyrosine kinase Etk/BMX alone is sufficient to transactivate Stat-mediated gene expression in salivary and lung epithelial cells. J Biol Chem 274 (1999) 38204-38210
23. de Araújo V.C., Furuse C., Cury P.R., Altemani A., and de Araújo N.S. Stat3 expression in salivary gland tumours. Oral Oncol 44 (2008) 439-445
24. World Health Organization classification of tumours. Tumours of the salivary glands. In: Barnes L., Eveson J.W., Reichart P., and Sidransky D. (Eds). Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon 209-281
25. Ellis G.L., and Auclair P.L. Atlas of tumor pathology, tumors of the salivary glands. In: Rosai J., and Sobin L.H. (Eds) (1996), Armed Forces Institute of Pathology, Washington (DC) Fascicle 17
26. Darnell Jr. J.E. Stats and gene regulation. Science 277 (1997) 1630-1635
27. Bromberg J., and Darnell Jr. J.E. The role of Stats in transcriptional control and their impact on cellular function. Oncogene 19 (2000) 2468-2473
28. Grandis J.R., Zeng Q., and Drenning S.D. Epidermal growth factor receptor-mediated Stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope 110 (2000) 868-874
29. Vered M., Braunstein E., and Buchner A. Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 24 (2002) 632-636
30. Fan C.Y., Melhem M.F., Hosal A.S., Grandis J.R., and Barnes E.L. Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma. Arch Otolaryngol Head Neck Surg 127 (2001) 1075-1079
31. Bu R., Purushotham K.R., Kerr M., Tao Z., Jonsson R., Olofsson J., et al. Alterations in the level of phosphotyrosine signal transduction constituents in human parotid tumors. Proc Soc Exp Biol Med 211 (1996) 257-264
32. Gibbons M.D., Manne U., Carroll W.R., Peters G.E., Weiss H.L., and Grizzle W.E. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope 111 (2001) 1373-1378
33. Giodini A., Kallio M.J., Wall N.R., Gorbsky G.J., Tognin S., and Marchisio P.C. Regulation of microtubule stability and mitotic progression by survivin (2002), 2462-2467, Cancer Res 62
34. Chiou S.K., Jones M.K., and Tarnawski A.J. Survivin-an antiapoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 9 (2003) 43-47
35. Ambrosini G., Adida C., and Altieri D.C. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3 (1997) 917-921
36. Weinman E.C., Roche P.C., Kasperbauer J.L., Cha S.S., Sargent D.J., Cheville J., et al. Characterization of antigen processing machinery and survivin expression in tonsillar squamous cell carcinoma. Cancer 97 (2003) 2203-2211
37. Jaskoll T., Chen H., Min Zhou Y., Wu D., and Melnick M. Developmental expression of survivin during embryonic submandibular salivary gland development. BMC Dev Biol 1 (2001) 5
38. Szlávik V., Vág J., Markó K., Demeter K., Madarász E., Oláh I., et al. Matrigel-induced acinar differentiation is followed by apoptosis in HSG cells. J Cell Biochem 103 (2008) 284-295
39. Scheper M.A., Nikitakis N.G., Chaisuparat R., Montaner S., and Sauk J.J. Sulindac induces apoptosis and inhibits tumor growth in vivo in head and neck squamous cell carcinoma. Neoplasia 9 (2007) 192-199